U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
One of the biggest challenges that doctors and scientists are faced with today is developing a cure for the deadly virus known as HIV or AIDS. Having become prevalent for decades, responsible for taking millions of lives, everyone is on the search for a cure, and patients are willing to risk their lives to make it happen.
As the HIV/AIDS epidemic rages on, there has been some progress made towards developing a cure to the deadly disease over recent years. A new study on the disease, titled “HIV Cure Research,” revealed that a portion of people who are HIV-positive are willing to risk their lives in the clinical trials. To them, they are willing to risk near-certain death if it means helping in developing a cure. According to a patient that was interviewed, “I’m not going to live forever… It is about the next man, the next woman, and you have to have the mindset to care about people, which I do.”
Another patient that was also interviewed explained that they are willing to go this far for the community living with the disease. They expressed their hope at how much of a game-changer it would be to see a cure made.
On the other hand, the authors of the study explained that if HIV-positive patients are allowed to volunteer for the experiments, they said that there should be ethical safeguards placed. This is to ensure that patients have a say in their involvement in research that has the possibility to be fatal for them.
Everyone is putting a united front in battling the disease to put a stop to the epidemic once and for all. Scientists from the University of Nebraska Medical Center and Temple University were able to come up with a kind of therapy that cured the virus of living animals. This was the biggest breakthrough towards the journey for the cure to HIV/AIDS, and the future is bright for the cure for humans.
According to Dr. Howard Gendelman of the University of Nebraska, they are moving closer to making human trials for the type of therapy that could potentially cure HIV/AIDS. Referred to as LASER-ART - which is a slow-effect release antiretroviral therapy, with a few more tests and experiments, it could be ready for human trials within the upcoming year or two.
